Regional Analysis
Global Mosquito Borne Disease Market- Regional Insights
- North America is expected to be the largest market for mosquito borne disease market during the forecast period, accounting for over 40.0% of the market share in 2023. The growth of the market in North America is attributed to high awareness, access to advanced treatments, presence of leading healthcare companies, and strong government support for elimination of mosquito borne diseases.
- Asia Pacific market is expected to be the second-largest market for mosquito borne disease market, accounting for over 31.1% of the market share in 2023. The growth of the market is attributed to high disease burden, tropical climate suiting mosquito growth, improving healthcare infrastructure and rising healthcare expenditure.
- Latin America market is expected to be the fastest-growing market for mosquito borne disease market, with a share of 19.2% during the forecast period. The growth of the market in Latin America is attributed to increasing incidence of mosquito borne diseases such as dengue, Zika and chikungunya in the region.
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
U.S.: 
U.K. : 
India : 
